Posted in | News | Microscopy | Nanoanalysis

ZEISS Crossbeam for High Speed Material Analysis to be Presented at MC 2013 in Regensburg, Germany

ZEISS will be presenting the first system of the new Crossbeam series at the MC 2013 in Regensburg, Germany.

Its outstanding features include high speed in materials analysis and processing and its wide diversity of applications. Time intensive 3D experiments that used to run for several days can now be completed overnight.

The newly developed focused ion beam (FIB) column enables fast and precise materials processing that can be observed with the field emission scanning electron microscope in real-time. High resolution over the entire voltage and current range allows users to work quickly and precisely.

Designed for stability, the system ensures reproducible results even in long-term experiments. The field of application is expanded by the optionally available Massive Ablation Laser that rapidly prepares samples to access deeply buried regions of interest. Crossbeam is suitable for use in both materials and life sciences. Materials scientists benefit from the excellent 3D analytics, the ability to image magnetic and non-conductive specimens with maximum resolution, and from the unique materials contrasts.

Bioscientists can use Crossbeam, above all, for fast tomography series with high Z resolution in cell and tissue biology. The STEM detection module delivers additional structural information. The system offers automated workflows, e.g. for TEM lamella preparation. At the same time, the open software offers users the possibility of integrating and automating their own applications. The modular design of Crossbeam makes it an open 3D nano workstation that can be configured and field-upgraded for a broad spectrum of today’s and future applications, therefore offering the user maximum flexibility.

The microscope system is available in two versions. The GEMINI I VP (variable pressure) column of Crossbeam 340 offers optimal analysis conditions for in situ experiments with outgassing and charging specimens. Thanks to the GEMINI II column with double condenser system, Crossbeam 540 users benefit from more information in a shorter time. The system delivers high resolution, even with low voltage and high beam current, enabling fast analytics and ease of use.

In combination with a ZEISS Xradia X-ray microscope (XRM), Crossbeam offers the possibility of complete specimen analysis across several orders of magnitude. The X-ray microscope first provides a 3D image of the specimen without destroying it before the identified areas of interest are processed with the focused ion beam and analyzed with the electron beam.

ZEISS

The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company's approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries.

ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

Microscopy

The Microscopy business group at ZEISS is the world's only manufacturer of light, X-ray and electron microscopes. The company's extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes,  

X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carl Zeiss Microscopy GmbH. (2019, February 11). ZEISS Crossbeam for High Speed Material Analysis to be Presented at MC 2013 in Regensburg, Germany. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=28806.

  • MLA

    Carl Zeiss Microscopy GmbH. "ZEISS Crossbeam for High Speed Material Analysis to be Presented at MC 2013 in Regensburg, Germany". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=28806>.

  • Chicago

    Carl Zeiss Microscopy GmbH. "ZEISS Crossbeam for High Speed Material Analysis to be Presented at MC 2013 in Regensburg, Germany". AZoNano. https://www.azonano.com/news.aspx?newsID=28806. (accessed November 23, 2024).

  • Harvard

    Carl Zeiss Microscopy GmbH. 2019. ZEISS Crossbeam for High Speed Material Analysis to be Presented at MC 2013 in Regensburg, Germany. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=28806.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.